The recent results of the Early Breast Cancer Trialists' Cooperative Group meta-analysis have demonstrated that post-mastectomy radiotherapy reduces breast cancer recurrence and mortality in women with positive axillary lymph nodes—independently from the number of the lymph nodes involved—with no significant effect in patients with node-negative axillary status.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Enhanced postoperative cancer therapy by iron-based hydrogels
Biomaterials Research Open Access 23 May 2022
-
A biodegradable thermo-responsive hybrid hydrogel: therapeutic applications in preventing the post-operative recurrence of breast cancer
NPG Asia Materials Open Access 14 August 2015
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
EBCTCG Early Breast Cancer Trialists' Collaborative Group. Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8,135 women in 22 randomised trials. Lancet http://dx.doi.org/10.1016/S0140-6736(14)60488-8.
Overgaard, M. et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b trial. N. Engl. J. Med. 337, 949–955 (1997).
Overgaard, M. et al. Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group 82c randomised trial. Lancet 353, 1641–1648 (1999).
Recth, A. et al. Locoregional failure 10 years after mastectomy and adjuvant chemotherapy with or without tamoxifen without irradiation: experience of the Eastern Cooperative Oncology Group. J. Clin. Oncol. 17, 1689–1700 (1999).
Katz, A. et al. Locoregional recurrence patterns after mastectomy and doxorubicin-based chemotherapy: implications for postoperative irradiation. J. Clin. Oncol. 18, 2817–2827 (2000).
Taghian, A. et al. Patterns of locoregional failure in patients with operable breast cancer treated by mastectomy and adjuvant chemotherapy with or without tamoxifen and without radiotherapy: results from the five National Surgical Adjuvant Breast and Bowel Project randomised clinical trials. J. Clin. Oncol. 22, 4247–4254 (2004).
Kim, S. I. et al. Clinical relevance of lymph node ratio in breast cancer patients with one to three positive lymph nodes. Br. J. Cancer 109, 1165–1171 (2013).
Shang, Y. P. et al. Radiotherapy can decrease locoregional recurrence and increase survival in mastectomy patients with T1 to T2 breast cancer and one to three positive nodes with negative estrogen receptor and positive lymphovascular invasion status. Int. J. Radiat. Oncol. Biol. Phys. 77, 516–522 (2010).
Botteri, E. et al. Mastectomy without radiotherapy: outcome analysis after 10 years of follow-up in a single institution. Breast Cancer Res. Treat. 134, 1221–1228 (2012).
Mukesh, M. B. et al. The Cambridge post-mastectomy radiotherapy (C-PMRT) index: a practical tool for patient selection. Radiother. Oncol. 110, 461–466 (2014).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Orecchia, R. Post-mastectomy radiotherapy reduces recurrence and mortality. Nat Rev Clin Oncol 11, 382–384 (2014). https://doi.org/10.1038/nrclinonc.2014.95
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrclinonc.2014.95
This article is cited by
-
European quality indicators developed by the European Commission Initiative on Breast Cancer: a first nationwide assessment for the Dutch setting
Breast Cancer Research and Treatment (2024)
-
Enhanced postoperative cancer therapy by iron-based hydrogels
Biomaterials Research (2022)
-
A biodegradable thermo-responsive hybrid hydrogel: therapeutic applications in preventing the post-operative recurrence of breast cancer
NPG Asia Materials (2015)